Recommendations about macroprolactin interference in the measurement of prolactin;Recomendaciones sobre las interferencias por macroprolactina en la medición de prolactina

Quimica Clinica

Volumn 25, Issue 1, 2006, Pages 45-48

  Douezi Lecha, Helene ^a   Güell Miró, Roser ^b   Ventura Pedret, Salvador ^b   Rodríguez, Ma Del Patrocinio Chueca ^b   Antoja Ribo F ^b   Casamajo Dalmau M T ^b   Castano Vidriales J L ^b   Chueca Rodriguez M P ^b   Domenech Clar, M V ^b   Douezi Lecha, H ^b   Fernandez Delclos M D ^b   Galimany Sole R ^b   Gelabert Orench, J M ^b   Guell Miro R ^b   Rojo Vizcaino I ^b   Ventura Pedret, S ^b  

^a Sociedad Espanola de Bioquimica Clinica y Patologia Molecular   (Spain)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; PROLACTIN; PROTEIN A;

CLINICAL FEATURE; GEL FILTRATION CHROMATOGRAPHY; HUMAN; HYPERPROLACTINEMIA; IMMUNOASSAY; IMMUNOPRECIPITATION; IN VIVO STUDY; PREVALENCE; REVIEW; ULTRAFILTRATION;

EID: 33646592568     PISSN: 11392436     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (41)

1. Touraine Ph, Kelly PA. La prolactine et ses récepteurs: de multiples actions aux mécanismes peu connus. Obtenido el 7 de abril del 2003 en: http://www.gyneweb.fr/sources/revues/referenc/vln3/prolactine.html.
2. Sapin R, Gasser F, Fischbach E, Grucker D. Détection de la macroprolactine: une nouvelle approche. Ann Biol Clin 2000; 58: 729-34.
3. Cattaneo F, Kappeler D, Müller B. Macroprolactinaemia, the major unknown in the differential diagnosis of hyperprolactinaemia. Swis Med Wkly 2001; 131: 122-6.
4. Jaquet P, Moatti P. Enquête diagnostique en pathologies hyperprolactinémiques. Ann Biol Clin 1999; 57: 330-3.
5. Schiettecatte J, Schepper J, Velkeniers B, Smitz J, Steirteghem A. Rapid detection of macroprolactin in the form of prolactin-immunoglobulin G complexes by immunoprecipitation with anti-human Ig G-agarose. Clin Chem Lab Med 2001; 39: 1244-8.
6. Olukoga AO, Kane JW. Macroprolactinaemia: validation and application of the polyethylene glycol precipitation test and clinical characterization of the condition. Clin Endocrinol 1999; 51: 119-26.
7. Cavaco B, Prazeres S, Santos MA, Sobrinho LG, Leite V. Hyperprolactinemia due to big big prolactin is differently detected by commercially available immunoassays. J Endocrinol Invest 1999; 22: 203-8.
8. Fahie-Wilson MN, Soule SG. Macroprolactinaemia: contribution to hyperprolactinaemia in a district general hospital and evaluation of a screening test based on precipitation with polyethylene glycol. Ann Clin Biochem 1997; 34: 252-8.
9. Leslie H, Courtney CH, Bell PM, Hadden DR, McCance DR, Ellis PK, et al. Laboratory and clinical experience in 55 patients with macroprolactinemia identified by a simple polyethylene glycol precipitation method. J Clin Endocrinol Metab 2001; 86: 2743-6.
10. Gilson G, Schmit P, Thix J, Hoffman JP, Humbel RL. Prolactin results for samples containing macroprolactin are method and sample dependent. Clin Chem 2001; 47: 331-3.
11. Hattori N. The frequency of macroprolactinemia in pregnant women and the heterogeneity of its etiologies. J Clin Endocrinol Metab 1996; 81: 586-90.
12. Suh HK, Frantz AG. Size heterogeneity of human prolactin in plasma and pituitary extracts. J Clin Endocrinol Metab 1974; 39: 928-35.
13. Bjoro T, Morkrid L, Wergeland R, Turter A, Kvistborg A, Sand T, et al. Frequency of hyperprolactinemia due to large molecular weight prolactin (150-170 kD PRL). Scand J Clin Lab Invest 1995; 55: 139-47.
14. Sanchez-Eixeres MR, Mauri M, Alfayate R, Graells ML, Miralles C, Lopez A et al. Prevalence of macroprolactin detected by Elecsys 2010. Horn Res 2001; 56: 87-92.
15. Toldy E, Löcsei Z, Kneffel P, Szabolcs I, Szöke J, Skrapits J et al. Macroprolactinemia: the consequences of a laboratory pitfall. Clin Chem Lab Med 2003; 41 (Suppl): M117.
16. Leite V, Cosby H, Sobrinho LG, Fresnoza A, Amparo Santos M, Friesen HG. Characterization of big big prolactin in patients with hyperprolactinaemia. Clin Endocrinol 1992; 37: 365-72.
17. Hauache OM, Rocha AJ, Maia AC, Maciel RM, Vieira JG. Screening for macroprolactinaemia and pituitary imaging studies. Clin Endocrinol 2002; 57: 327-31.
18. García L, Díez A, Ciriza de los Ríos C, Delgado M, Orejas A, Fernández AL et al. Macroprolactina como causa de hiperprolactinemia. Método de detección y caracterización clínica en 39 pacientes. Rev Clin Esp 2003; 203: 459-64.
19. Vallette-Kasic S, Morange-Ramos I, Selim A, Gunz G, Morange S, Enjalbert A et al. J Clin Endocrinol Metab 2002; 87: 2581-8.
20. Diver MJ, Ewins DL, Worth RC, Bowles S, Ahlquist JA, Fahie-Wilson MN. An unusual form of big, big (macro) prolactin in a pregnant patient. Clin Chem 2001; 47: 346-8.
21. Fahie-Wilson MN and John R. Detection of macroprolactin causing hyperprolactinemia in commercial assays for prolactin Dr. John responds: Clin Chem 2000; 46: 2022-3.
22. Fahie-Wilson MN. Detection of macroprolactin causing hyperprolactinemia in commercial assays for prolactin. Clin Chem 2000; 46: 2022.
23. Schneider W, Marcovitz S, Al-Shammari S, Yago S, Chevalier S. Reactivity of macroprolactin in common automated immunoassays. Clin Biochem 2001; 34: 469-73.
24. John R, McDowell IFW, Scanlon MF, Ellis AR. Macroprolactin reactivities in prolactin assays: an issue for clinical laboratories and equipment manufacturers. Clin Chem 2000; 46: 884-5.
25. Smith TP, Suliman AM, Fahie-Wilson MN, McKenna TJ. Gross variability in the detection of prolactin in sera containing big big prolactin (macroprolactin) by commercial immunoassays. J Clin Endocrinol Metab 2002; 87: 5410-5.
26. Schlechte JA. The macroprolactin problem. J Clin Endocrinol Metab 2002; 87: 5408-9.
27. Toffaletti J, Savory J, Gitelman HJ. Use of gel filtration to examine the distribution of calcium among serum proteins. Clin Chem 1977; 23: 2306-10.
28. Vieira JG, Tachibana TT, Obara LH, Maciel RM. Extensive experience and validation of polyethylene glycol precipitation as a screening method for macroprolactinemia. Clin Chem 1998; 44: 1758-9.
29. Hattori N, Ikekubo K, Ishihara T, Moridera K, Hino M, Kurahachi H. Correlation of the antibody titers with serum prolactin levels and their clinical course in patients with anti-prolactin autoantibody. Eur J Endocrinol 1994; 130. 438-45.
30. Hattori N, Ikekubo K, Ishihara T, Moridera K, Hino M, Kurahachi H. Effects of anti-prolactin autoantibodies on serum prolactin measurements. Eur J Endocrinol 1994; 130: 434-47.
31. Rivero A, Alonso E, Grijalba A. Decisión cut-off of the polyethylene glycol precipitation technique in screening for macroprolactinemia on Immunolite 2000. Clin Chem Lab Med 2004; 42(5): 566-8.
32. Li W, Sustarsic D, Fahie-Wilson M, Vankrieken L, Quero K, Del Rosario I et al. Matrix effect of PEG precipitation in detection of macroprolactin in Immulite and Immulite 2000 prolactin assay. Clin Chem 2002, 48 (Suppl 6): A62.
33. Amadori P, Dilberis C, Marcolla A, Pinamonti M, Menapace P, Del Bosco F. Macroprolactinemia: predictability on clinical basis and detection by PEG precipitation with two different immunometric methods. J Endocrinol Invest 2003; 26: 148-56.
34. Suliman AM, Smith TP, Gibney J, McKenna TJ. Frequent misdiagnosis and mismanagement of hiperprolactinemic patients before the introduction of macroprolactin screening: application of a new strict laboratory definition of macroprolactinemia. Clin Chem 2003; 49: 1504-9.
35. Kertesz G, Casano B, Morel Montera A, Valette-Kasic S, Brue T. Validation of a simple screening meted for macroprolactin by comparison with gel filtration chromatography. Clin Chem Lab Med 2001; 39 (Suppl): S245.
36. Sapin R, Kertesz G. Macroprolactin detection by precipitation with protein A-sepharose: a rapid screening method compared with polyethylene glycol precipitation. Clin Chem. 2003; 49: 502-5.
37. Fahie-Wilson M, Brunsden P, Surrey J, Everitt A. Macroprolactin and the Roche Elecsys prolactin assay: characteristics of the reaction and detection by precipitation with polyethylene glycol. Clin Chem 2000; 46: 1993-5.
38. Sapin R, Gasser F, Grucker D. Free prolactin determinations in hyperprolactinemic men with suspicion of macroprolactinemia. Clin Chim Acta 2002; 316: 33-41.
39. Ismail AAA, Walker PL, Fahie-Wilson MN, Jassam N, Barth JH. Prolactin and macroprolactin: a case report of hyperprolactinaemia high-lighting the interpretation of discrepant results. Ann Clin Biochem 2003; 40: 298-300.
40. Prazeres S, Santos MA, Ferreira HG, Sobrinho LG. A practical method for the detection of macroprolactinaemia using ultrafiltration. Clin Endocrinol 2003; 58: 686-90.
41. Fahie-Wilson MN, Ahlquist JA. Hyperprolactinaemia due to macroprolactins: some progress but still a problem. Clin Endocrinol 2003; 58: 683-5.